| 摘要 |
The invention relates to the use of a compound of formula (I):
its pharmaceutically acceptable salts, and/or solvates, in the preparation of a medicinal product for the treatment of a disease presenting altered adiponectin levels or in which it is necessary to alter the adiponectin levels, in particular diabetes, obesity, metabolic syndrome, arteriosclerotic cardiovascular disease, dyslipidemia and lipodystrophy.
|
